Back to Search
ANNA FISHBEIN
Student in an Organized Health Care Education/Training Program
NPI: 1780382200Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (6)
Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families.
PMID 30345457·Dermatol Ther (Heidelb)·2018
8-other
Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2-high atopic dermatitis disease endotype.
PMID 29309794·J Allergy Clin Immunol·2018
3-trial
Crisaborole: Phosphodiesterase inhibitor for treatment of atopic dermatitis.
PMID 28492291·Drugs Today (Barc)·2017
6-review
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.
PMID 27417017·J Am Acad Dermatol·2016
3-trial
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.
PMID 25482871·J Allergy Clin Immunol·2014
3-trial
The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis.
PMID 16061782·Arch Pediatr Adolesc Med·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3600 RESERVOIR RD NW
WASHINGTON, DC 20007 - Phone
- (202) 444-2000
Quick Facts
- NPI
- 1780382200
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 6
Are you this provider?
Claim Your Profile